Public perspectives on supervised consumption sites across Canada
A cross-sectional study
Bibliographic Data
| ID | 21594797 |
|---|---|
| Authors | William Rioux (0000-0003-4278-9751, University of Alberta, corresponding author), Nathan Rider (0009-0003-2424-6005, University of Calgary), Boogyung Seo (0000-0002-0016-2355, University of Alberta), Dylan Viste (0000-0002-5340-2682, University of Calgary), Bo Pan (0009-0009-4561-2469, University of Alberta), Yazid Al Hamarneh (University of Alberta), S Monty Ghosh (0000-0002-1566-0015, University of Alberta) |
| Year | 2026 |
| Volume | 155 |
| Pages | 105411 |
| Publication date | 2026-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2026.105411 |
| PMID | 42349281 |
| OpenAlex | W7165927124 |
| Language | EN |
| References cited | 40 |
INTRODUCTION: Canada continues to face high rates of drug poisoning, prompting the implementation of harm reduction measures, including supervised consumption sites (SCS). SCS remain politically and socially contested despite evidence supporting their effectiveness. Given recent debates on SCS operations and limited national data on public perceptions of them, this study examined data from a large bilingual pan-Canadian survey to assess attitudes of the general public towards SCS. METHODS: This study utilized data from a national online cross-sectional survey, the Canadian National Questionnaire on Overdose Monitoring (CNQOM). Likert-based questionnaire items evaluated public perceptions of SCS elements. The study examined the general public's perspectives towards SCS client considerations (e.g. safety), community impacts (e.g. discarded needles), and health system impacts (e.g. use of emergency services). CNQOM data was analyzed using the Wilcoxon Signed Rank Test. RESULTS: Between July 2022 and May 2023, out of 2866 valid participants, the general public perceived SCSs to have positive impacts on overdose and infection risk, improved access to healthcare, harm reduction, and social services. Respondents perceived SCS as effective in increasing education and awareness, particularly for people who use substances (PWUS), and viewed these services as appropriate across diverse populations and settings, including rural areas and acute care. Respondents felt SCSs reduced public drug use and discarded needles, but perceptions of broader community effects such as crime, public safety, and property values trended to be more neutral. Similarly, participants viewed SCS as enhancing safety for healthcare providers with neutral effects of healthcare system use and provider burnout. CONCLUSION: Members of the general public generally perceived SCS as beneficial for clients. Furthermore, participants did not identify SCS as having negative impacts on communities or health systems overall. Governments should consider these findings when making decisions about implementing SCS, modifying services, or closing SCS in their jurisdictions. Our findings are informative for harm reduction program planning and policy development at the national and provincial or state levels
Poison control · Public health · Suicide prevention · Focus Groups and Qualitative Methods · Human Factors and Ergonomics · Social and Cultural Dynamics · Survey Methodology and Nonresponse
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility
Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities
Supervised Injection Facilities as Harm Reduction
Improving the Quality of Web Surveys
Responding to the opioid crisis in North America and beyond
Risk creating and risk reducing
Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France
Spatial-temporal trends in the risk of illicit drug toxicity death in British Columbia
Determinants of hospitalization for a cutaneous injection-related infection among injection drug users
Virtual overdose monitoring services and overdose prevention technologies
The prospect of implementing a Safer Injection Facility in San Francisco
Assessing support for supervised injection services among community stakeholders in London, Canada
Changes in public order after the opening of an overdose monitoring facility for people who inject drugs
Canadian harm reduction policies
A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility
Covid-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services
Flawed reports can harm
| Citation velocity | historical |
|---|---|
| Highly cited | No |